COMMUNIQUÉS West-GlobeNewswire

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
05/01/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase III part of the Phase [...]
Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia
04/01/2026
SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET to provide [...]
Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects
04/01/2026
Strongest sleep aid over the counter sleep Pills NooCube best for sleep and anxiety read side effects, benefits, ingredients of NooCube supplement New York City, Jan. 04, 2026 (GLOBE NEWSWIRE) -- In 2026 Getting good [...]
Best Male Enhancement Pills 2026: Launched By Performer 8' Over The Counter ED Pills For Erectile Dysfunction, Growth & Last Longer for Men
04/01/2026
best male enhancement pills sold in stores' Pills for Erectile dysfunction for men, Effective Formula for last longer and testosterones booster Quality Criteria Examined in New Industry Analysis New York City,, Jan. 04 [...]
CystoSmart™, an AI Software Tool for Bladder Cancer Detection, Developed with Cutting-Edge Technology Receives Clearance from Health Sciences Authority Singapore
04/01/2026
SINGAPORE and LONDON and NEW YORK, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology and [...]
CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk
04/01/2026
Discover how CJC-1295 peptide stack research has influenced CrazyBulk’s Growth Hormone Stack, designed to support recovery speed, lean muscle, and training output. Intro New York City, NY, Jan. 04, 2026 (GLOBE NEWSWIRE [...]
Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges
03/01/2026
Consumer analysis evaluates Earth Echo Cacao Bliss ingredient disclosures, ceremonial-grade processing claims, and published GLP-1 research frequently referenced in chocolate-based weight management supplement [...]
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/01/2026
CAMBRIDGE, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
GH Research to Announce IND Status for GH001
02/01/2026
DUBLIN, Jan. 02, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in [...]
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
02/01/2026
ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02/01/2026
FOSTER CITY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of January 1, 2026 [...]
Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
02/01/2026
TARRYTOWN, N.Y., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its fourth quarter and full year 2025 financial and operating results on Friday, [...]
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02/01/2026
NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain
02/01/2026
Clinic’s consistent 4.7-star rating reflects nearly four decades of patient trust, care quality, and international recognition in the field of aesthetic surgery Zaragoza, Aragón, Jan. 02, 2026 (GLOBE NEWSWIRE) -- [...]
Mint Ops Launches Its Fifth Division: Transition Consulting to Support Dental Clinic Owners Through Growth, Buy/Sell Decisions, and Operational Success
02/01/2026
Winnipeg, Manitoba, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Mint Ops Logo FOR IMMEDIATE RELEASE Winnipeg, MB - January 2nd, 2026 - Mint Ops, a national ecosystem of services supporting dental clinics across Canada, today [...]
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
02/01/2026
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, [...]
Nova Leap Health Corp. Announces Promotion of Melissa Anderson to Senior Vice President, United States
02/01/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Jan. 02, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Cannara atteint #1 en parts de marché au Québec en décembre 2025 et présente une mise à jour sur le lancement de ses produits de vapotage au Québec
02/01/2026
MONTRÉAL, Québec, 02 janv. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSXV : LOVE ) ( OTCQB : LOVFF ) ( FRA : 8CB0) , producteur verticalement intégré de [...]
Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
02/01/2026
MONTREAL, Québec, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade [...]

Pages